Phreesia Names Alexandra Beneville Vice President of Life Sciences Content Strategy
22 September 2022 - 10:27PM
Business Wire
Phreesia, a leader in patient intake, outreach and activation,
has named Alexandra Beneville as Vice President of Life Sciences
Content Strategy. Beneville officially joined Phreesia on Aug. 1,
2022, from Phosphorus, a direct-to-consumer genomic testing
company, where she had served as Vice President of Marketing since
December 2021.
In her new role, Beneville will oversee the Phreesia Life
Sciences Content Strategy team, spearheading its digital patient
engagement campaigns across the Phreesia platform. She brings more
than 20 years of marketing and brand-management experience to
Phreesia, including leadership positions with several
healthcare-industry companies.
“I am thrilled to welcome Alex to our Life Sciences leadership
team,” said David Linetsky, Phreesia’s Senior Vice President, Life
Sciences. “I believe her depth and breadth of experience will be
invaluable to our ongoing efforts to activate patients to drive
positive health outcomes at scale.”
Prior to leading Phosphorus’ marketing efforts, Beneville held a
variety of leadership roles at global marketing communications
agency, Wunderman. Most recently, she served as Managing Director
of Wunderman Thompson Japan in Tokyo, overseeing the company’s
global-to-local marketing implementation, as well as domestic
campaigns and clients. Before moving to Tokyo, she served as Senior
Vice President, Group Account Director of Wunderman Health DC for
nearly a decade, preceded by several years as a Vice President,
Account Director at Saatchi & Saatchi Healthcare
Advertising.
Beneville began her career at Eli Lilly Global Marketing, and
she has broad experience in therapeutic categories including
oncology, gastroenterology, rheumatology and women’s health.
Beneville holds a BA in History from Smith College, and an MBA and
MA in Middle East Studies from the University of Chicago.
“I’m a firm believer in the positive impact that patient
communications and direct-to-consumer marketing can have in
creating an improved healthcare experience,” Beneville said. “I’m
looking forward to leading the Content Strategy team and supporting
Phreesia’s work to positively impact patient health.”
About Phreesia Life
Sciences
Phreesia empowers life sciences companies to connect
meaningfully with clinically relevant patients, delivering targeted
health content in a one-to-one setting. Our PatientConnect offering
identifies and motivates the right patients to initiate meaningful
brand conversations, and our PatientInsights product enables our
clients to better understand their target patient populations.
Phreesia meets patients where they are, both virtually and
in-person, and reaches them at multiple touch points throughout
their healthcare journey.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220922005891/en/
Media: Carly Helfand
chelfand@phreesia.com 332-910-6768
Phreesia (NYSE:PHR)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Phreesia (NYSE:PHR)
Historical Stock Chart
Von Mär 2023 bis Mär 2024